Devy Setyono, MD
Rheumatology · Honolulu, HINPI 1962815878
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,218 and has fallen 81.4% since, to $413 in 2025.
Across 376 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- Johnson & Johnson$570
- AstraZeneca$540
- E.r. Squibb & Sons, L.L.C.$455
- GSK$398
- plus $3K from 29 others
What the payments were for
- Consulting fees$1001%
- Food & beverage$8,52097%
- Education$1852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 81 | $2,088 |
| AbbVie | 107 | $1,826 |
| Johnson & Johnson(2 entities) | 19 | $570 |
| AstraZeneca(2 entities) | 23 | $540 |
| E.r. Squibb & Sons, L.L.C. | 23 | $455 |
| GSK | 16 | $398 |
| Lilly USA, LLC | 13 | $289 |
| Radius Health, Inc. | 9 | $258 |
| Aurinia Pharma U.S., Inc. | 10 | $230 |
| Janssen Scientific Affairs, LLC | 2 | $215 |
| Mallinckrodt Hospital Products Inc. | 6 | $198 |
| UCB, Inc. | 6 | $187 |
| Pfizer | 10 | $165 |
| ANI Pharmaceuticals, Inc. | 7 | $158 |
| Sanofi | 2 | $142 |
| Novartis | 3 | $132 |
| Genentech USA, Inc. | 7 | $125 |
| Cardinal Health 110 LLC | 1 | $100 |
| Sobi, Inc | 4 | $95 |
| Actelion Pharmaceuticals US, Inc. | 3 | $81 |
| Ultragenyx Pharmaceutical Inc. | 5 | $78 |
| Sanofi-aventis U.S. LLC | 1 | $77 |
| Boehringer Ingelheim | 4 | $73 |
| Organon | 2 | $54 |
| Fidia Pharma USA Inc. | 2 | $47 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $31 |
| Mallinckrodt Enterprises LLC | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Bristol Myers Squibb | 1 | $20 |
| Orthogenrx Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Bioventus LLC | 1 | $15 |
| Tersera Therapeutics LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,805 in reported general payments places this provider in the 75th percentile of 21 rheumatology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $101,089 |
| Xeljanz XrTofacitinib Citrate | 14 | $80,198 |
| Orencia ClickjectAbatacept | 11 | $61,460 |
| Hydroxychloroquine Sulfate | 76 | $3,206 |
| Colchicine | 40 | $2,596 |
| Mycophenolate Mofetil | 14 | $2,083 |
| MethotrexateMethotrexate Sodium | 52 | $1,780 |
| Febuxostat | 11 | $1,463 |
| Ibandronate Sodium | 20 | $883 |
| Leflunomide | 17 | $798 |
| Allopurinol | 35 | $643 |
| Duloxetine Hcl | 41 | $591 |
| Alendronate Sodium | 92 | $581 |
| Gabapentin | 36 | $501 |
| Prednisone | 79 | $414 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Honolulu
- Scott KawamotoHonolulu$58K
- Daniel BrandtHonolulu$29K
- Kristine UramotoHonolulu$26K
- Deryll AmbrocioHonolulu$21K
- Mari ShiraishiHonolulu$9K
- Sadao JinnoHonolulu$6K
- Heejae JungHonolulu$4K
- Denny NakayamaHonolulu$3K
- Ken ArakawaHonolulu$3K
- Alberto Santos-OcampoHonolulu$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.